patient is cancer free. But even if only a few cells remain after surgery, the cancer may recur and spread,” said Satchi-Fainaro, who is president of the Israeli chapter of the Controlled Release Society and co-editor-in-chief of the journal Clinical Cancer Drugs. “Our new technology can guide the surgeon to
completely excise the cancer.”
The TAU technique makes use of near-infrared technology to find proliferating cancer cells. “The probe is a polymer that connects to a fluorescent tag made of molecules of cyanine dye using a ‘linker,’ which is recognized by an enzyme called cathepsin. This substance is overproduced in many cancer types,” she explained.